|
Subject
|
Year
|
Volume
|
Part
|
|
Infections In Obstetrics
|
1997
|
11
|
1
|
|
Noscocomial Infections
|
1997
|
11
|
2
|
|
Urinary Tract Infections
|
1997
|
11
|
3
|
|
Antimicrobial Resistance
|
1997
|
11
|
4
|
|
Emerging Infectious Diseases
|
1998
|
12
|
1
|
|
Travel Medicine
|
1998
|
12
|
2
|
|
Lower Respiratory Tract Infections
|
1998
|
12
|
3
|
|
Outpatient Parenteral Antimicrobial Therapy
|
1998
|
12
|
4
|
|
New Vaccines and New Vaccine Technology
|
1999
|
13
|
1
|
|
Bacterial Sepsis and Septic Shock
|
1999
|
13
|
2
|
|
Bacterial Meningitis
|
1999
|
13
|
3
|
|
Emerging and Re-Emerging Diseases in Latin America
|
2000
|
14
|
1
|
|
Antibacterial Therapy
|
2000
|
14
|
2
|
|
Infections of the Liver
|
2000
|
14
|
3
|
|
HIV/Aids 2000
|
2000
|
14
|
4
|
|
Vaccine Recommendations
|
2001
|
15
|
1
|
|
Infections in the Compromised Host
|
2001
|
15
|
2
|
|
Infections in Patients with Chronic Renal Failure
|
2001
|
15
|
3
|
|
The Role of the Clinical Microbiology Laboratory
in the Diagnosis and Therapy of Infectious Disease
|
2001
|
15
|
4
|
|
Mycobacterial Infections
|
2002
|
16
|
1
|
|
Infective Endocarditis
|
2002
|
16
|
2
|
|
Infections in Injection Drug Users
|
2002
|
16
|
3
|
|
Fungal Infections: Part I
|
2002
|
16
|
4
|
|
Fungal Infections: Part II
|
2003
|
17
|
1
|
|
Urinary Tract Infections
|
2003
|
17
|
2
|
|
Clinical Implications of Antimicrobial Pharmacokinetics
|
2003
|
17
|
3
|
|
Hospital-Aquired Pneumonia: European Perspective
|
2003
|
17
|
4
|
|
Historical Aspects of Infectious Diseases, Part I
|
2004
|
18
|
1
|
|
Historical Aspects of Infectious Diseases, Part II
|
2004
|
18
|
2
|
|
Antibacterial Therapy and Newer Agents
|
2004
|
18
|
3
|
|
Lower Respiratory Tract Infections
|
2004
|
18
|
4
|
|
Travel and Tropical Medicine
|
2005
|
19
|
1
|
|
Sexually Transmitted Infections
|
2005
|
19
|
2
|
|
Pediatric Infectious Diseases
|
2005
|
19
|
3
|
|
Update on Musculoskeletal Infections
|
2005
|
19
|
4
|
|
Hepatitis
|
2006
|
20
|
1
|
|
Bioterrorism and Bioterrorism Preparedness
|
2006
|
20
|
2
|
|
Fungal Infections
|
2006
|
20
|
3
|
|
Infections and Rheumatic Diseases
|
2006
|
20
|
4
|
|
HIV/AIDS
|
2007
|
21
|
1
|
|
Infections of the Head and Neck
|
2007
|
21
|
2
|
|
Infection in High-Risk Populations
|
2007
|
21
|
3
|
|
Fever of Unknown Origin
|
2007
|
21
|
4
|
|
Tick-borne Diseases, Part I: Lyme Disease
|
2008
|
22
|
2
|
|
Tick-borne Diseases, Part II: Other Tick-borne Diseases
|
2008
|
22
|
3
|
|
Infectious Diseases in Women
|
2008
|
22
|
4
|
|
Staphylococcal Infections
|
2009
|
23
|
1
|
|
Meta-analysis in Infectious Diseases
|
2009
|
23
|
2
|
|
Infections in the Intensive Care Unit
|
2009
|
23
|
3
|
|
Antibacterial Therapy and Newer Agents
|
2009
|
23
|
4
|
|
The Atypical Pneumonias
|
2010
|
24
|
1
|
|
Infections in Transplant and Oncology Patients
|
2010
|
24
|
2
|
|
Emerging Respiratory Infections in the 21st Century
|
2010
|
24
|
3
|
|
Diseases of the Gastrointestinal Tract and Associated Infections
|
2010
|
24
|
4
|
|
Infection Prevention and Control in the Hospital
|
2011
|
25
|
1
|
|
Global Health, Global Health Education, and Infectious Disease:
the New Millennium Part I
|
2011
|
25
|
2
|
|
Global Health, Global Health Education, and Infectious Disease:
the New Millennium Part II
|
2011
|
25
|
3
|
|
Biologic Response Modifiers in Infectious Disease
|
2011
|
25
|
4
|